Compugroup Medical SE & Co. KGaA
CMPVF
$33.66
$9.8641.45%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 12.79% | 19.40% | 10.11% | -2.32% | -2.09% |
| Total Other Revenue | -86.12% | -- | -- | -- | 438.34% |
| Total Revenue | 12.60% | 19.43% | 10.11% | -2.32% | -1.94% |
| Cost of Revenue | 11.77% | 17.84% | 11.42% | -1.20% | -11.37% |
| Gross Profit | 14.20% | 22.55% | 7.48% | -4.46% | 23.34% |
| SG&A Expenses | -47.32% | 365.76% | -16.42% | 863.44% | -3.92% |
| Depreciation & Amortization | 4.66% | 2.48% | -0.50% | -0.71% | 8.08% |
| Other Operating Expenses | 11.69% | 36.98% | 39.70% | 17.83% | 43.57% |
| Total Operating Expenses | 7.77% | 21.83% | 13.94% | 2.71% | -2.93% |
| Operating Income | 157.22% | -4.22% | -27.00% | -40.37% | 41.55% |
| Income Before Tax | 416.23% | 47.95% | -58.94% | -41.78% | 119.10% |
| Income Tax Expenses | 23.26% | 214.55% | -57.64% | -41.81% | 394.51% |
| Earnings from Continuing Operations | 211.86% | -23.46% | -59.49% | -41.77% | 61.40% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 72.14% | -491.52% | -213.61% | -200.00% | -2.33% |
| Net Income | 202.51% | -25.09% | -60.77% | -42.85% | 59.72% |
| EBIT | 157.22% | -4.22% | -27.00% | -40.37% | 41.55% |
| EBITDA | 72.45% | -20.01% | -13.33% | -23.05% | -49.20% |
| EPS Basic | 201.41% | -25.15% | -60.78% | -42.30% | 58.88% |
| Normalized Basic EPS | 928.99% | 40.32% | -59.94% | -42.47% | 78.93% |
| EPS Diluted | 199.26% | -23.59% | -60.85% | -42.58% | 58.88% |
| Normalized Diluted EPS | 924.28% | 41.49% | -60.13% | -43.23% | 78.93% |
| Average Basic Shares Outstanding | 1.09% | 0.05% | 0.04% | -0.95% | -2.02% |
| Average Diluted Shares Outstanding | 1.64% | -0.79% | 0.51% | 0.42% | -2.02% |
| Dividend Per Share | -- | -- | -- | -- | -95.05% |
| Payout Ratio | -- | -- | -- | -- | -- |